Naoko Kamo1, Bibo Ke, Ronald W Busuttil, Jerzy W Kupiec-Weglinski. 1. Dumont-UCLA Transplant Center, Division of Liver and Pancreas Transplantation, Department of Surgery, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA.
Abstract
UNLABELLED: The phosphatase and tensin homolog deleted on chromosome 10 (PTEN) regulates innate immune responses inversely with phosphoinositide 3-kinase (PI3K) and its direct downstream target gene, Akt. The Forkhead box O (Foxo) transcription factors are essential in the regulation of tissue development, immune homeostasis, and cell survival. This study was designed to investigate the role of PTEN-mediated Akt/β-catenin/Foxo1 signaling in the regulation of in vivo and in vitro innate immune responses in a mouse model of hepatic inflammatory injury induced by 90 minutes of liver partial warm ischemia followed by 6 hours of reperfusion. We found that knockdown of PTEN with small interfering RNA (siRNA) promoted Akt/β-catenin/Foxo1 signaling, leading to resistance against liver ischemia/reperfusion (IR) damage, local enhancement of antiapoptotic function, and downregulation of innate Toll-like receptor 4 (TLR4) expression. A specific PI3K blockade inhibited Akt/β-catenin signaling, increased Foxo1-mediated TLR4-driven local inflammation, and recreated cardinal features of liver IR injury. Moreover, knockdown of PTEN in lipopolysaccharide-stimulated mouse bone marrow-derived macrophages enhanced β-catenin activity, which in turn provided a negative regulatory feedback to the Foxo1 function, leading to the inhibition of TLR4 and NF-κB, with ultimate depression of proinflammatory cytokine programs in vitro. CONCLUSION: Our novel findings identify the PTEN-mediated Akt/β-catenin/Foxo1 axis as a key regulator of innate inflammatory response in the mouse liver. By identifying molecular mechanisms of PTEN-mediated Akt/β-catenin/Foxo1 signaling in TLR4 innate immune regulation, our study provides a rationale for therapeutic approaches to manage inflammation injury in IR-stressed liver.
UNLABELLED: The phosphatase and tensin homolog deleted on chromosome 10 (PTEN) regulates innate immune responses inversely with phosphoinositide 3-kinase (PI3K) and its direct downstream target gene, Akt. The Forkhead box O (Foxo) transcription factors are essential in the regulation of tissue development, immune homeostasis, and cell survival. This study was designed to investigate the role of PTEN-mediated Akt/β-catenin/Foxo1 signaling in the regulation of in vivo and in vitro innate immune responses in a mouse model of hepatic inflammatory injury induced by 90 minutes of liver partial warm ischemia followed by 6 hours of reperfusion. We found that knockdown of PTEN with small interfering RNA (siRNA) promoted Akt/β-catenin/Foxo1 signaling, leading to resistance against liver ischemia/reperfusion (IR) damage, local enhancement of antiapoptotic function, and downregulation of innate Toll-like receptor 4 (TLR4) expression. A specific PI3K blockade inhibited Akt/β-catenin signaling, increased Foxo1-mediated TLR4-driven local inflammation, and recreated cardinal features of liver IR injury. Moreover, knockdown of PTEN in lipopolysaccharide-stimulated mouse bone marrow-derived macrophages enhanced β-catenin activity, which in turn provided a negative regulatory feedback to the Foxo1 function, leading to the inhibition of TLR4 and NF-κB, with ultimate depression of proinflammatory cytokine programs in vitro. CONCLUSION: Our novel findings identify the PTEN-mediated Akt/β-catenin/Foxo1 axis as a key regulator of innate inflammatory response in the mouse liver. By identifying molecular mechanisms of PTEN-mediated Akt/β-catenin/Foxo1 signaling in TLR4 innate immune regulation, our study provides a rationale for therapeutic approaches to manage inflammation injury in IR-stressed liver.
Authors: Shivapriya Ramaswamy; Noriaki Nakamura; Isabelle Sansal; Louise Bergeron; William R Sellers Journal: Cancer Cell Date: 2002-07 Impact factor: 31.743
Authors: Bibo Ke; Xiu-Da Shen; Haofeng Ji; Naoko Kamo; Feng Gao; Maria Cecilia S Freitas; Ronald W Busuttil; Jerzy W Kupiec-Weglinski Journal: J Hepatol Date: 2011-07-12 Impact factor: 25.083
Authors: N Omori; G Jin; F Li; W R Zhang; S J Wang; Y Hamakawa; I Nagano; Y Manabe; M Shoji; K Abe Journal: Brain Res Date: 2002-11-08 Impact factor: 3.252
Authors: J O Lee; H Yang; M M Georgescu; A Di Cristofano; T Maehama; Y Shi; J E Dixon; P Pandolfi; N P Pavletich Journal: Cell Date: 1999-10-29 Impact factor: 41.582
Authors: Hugo Stocker; Mirjana Andjelkovic; Sean Oldham; Muriel Laffargue; Matthias P Wymann; Brian A Hemmings; Ernst Hafen Journal: Science Date: 2002-02-28 Impact factor: 47.728
Authors: Xiu-Da Shen; Bibo Ke; Yuan Zhai; Farin Amersi; Feng Gao; Dean M Anselmo; Ronald W Busuttil; Jerzy W Kupiec-Weglinski Journal: Transplantation Date: 2002-08-15 Impact factor: 4.939
Authors: Margaret A T Freeberg; Anas Easa; Jacquelyn A Lillis; Danielle S W Benoit; Andre J van Wijnen; Hani A Awad Journal: J Orthop Res Date: 2019-09-01 Impact factor: 3.494
Authors: Qiang Zhu; Changyong Li; Kunpeng Wang; Shi Yue; Longfeng Jiang; Michael Ke; Ronald W Busuttil; Jerzy W Kupiec-Weglinski; Feng Zhang; Ling Lu; Bibo Ke Journal: Liver Transpl Date: 2017-06 Impact factor: 5.799
Authors: Kojiro Nakamura; Min Zhang; Shoichi Kageyama; Bibo Ke; Takehiro Fujii; Rebecca A Sosa; Elaine F Reed; Nakul Datta; Ali Zarrinpar; Ronald W Busuttil; Jesus A Araujo; Jerzy W Kupiec-Weglinski Journal: J Hepatol Date: 2017-08-23 Impact factor: 25.083